|
|
Post by JHam on Jul 1, 2020 1:17:56 GMT
Opening a new thread to discuss these kind of stocks in general, in order to avoid cluttering up the individual boards.
The low float microcap software sector has been on a pre-earnings run.
POLA (which I watch but have never owned), CPSH, CLSK and have been on a tear as of late.
QUIK (my 2nd largest holding) has not had one of these runs yet, but huge news about a long term initiative with a “mega-cap” company is expected any day now. Seeing that it hasn’t had a bump going into earnings, I think it is primed to take off on this news.
CPAH (my largest holding), has slowly crept up the ladder over the last few months from the high $2s to $5. I think the stock has slowly gone into stronger hands, but has the potential to really move on good earnings.
I just got back into CLSK after the last few days of a big pump/dump. The CEO said in his last interview that some new collaborations will be announced towards the end of Q2. Q2 ended today so it should be any day now. I’m not sure if it will pop on the news since the stock had been red hot as of late. It may need to cool down for a bit. It’s kind of a cult stock with a lot of pumpers so you never know how it will react.
|
|
|
|
Post by magnus123 on Jul 1, 2020 10:39:21 GMT
Would like to add IDXG to that list. They had no run so far, but a lot of volume and volatility in the $4 range.
|
|
|
|
Post by JHam on Jul 1, 2020 11:34:33 GMT
Would like to add IDXG to that list. They had no run so far, but a lot of volume and volatility in the $4 range. Nice idea! I opened this thread because I think there are so many potential huge gainers right now, and I wanted everyone to be able to talk freely about different stocks without having to worry about breaking the rules of the board (talking about different stocks in a certain forum). My current plan is, hopefully, to take any profits from QUIK and roll them into either CLSK or CPAH (or both) prior to ER, and then sell some trading shares and keep my core positions. I'm also looking to get back into SOLY and hold through the 510K filing, selling some, and holding through FDA approval. That's the current strategy, which could change at any time of course. I'll take a look at IDXG too, and see if/how I should incorporate it into my short term strategy. |
|
|
|
Post by JHam on Jul 1, 2020 11:46:38 GMT
Good lord, sorry for all the typos in that first post (now corrected). I often type on my phone on the train, and auto-correct does its thing  |
|
|
|
Post by JHam on Jul 1, 2020 12:11:21 GMT
Would like to add IDXG to that list. They had no run so far, but a lot of volume and volatility in the $4 range. Nice idea! I opened this thread because I think there are so many potential huge gainers right now, and I wanted everyone to be able to talk freely about different stocks without having to worry about breaking the rules of the board (talking about different stocks in a certain forum). My current plan is, hopefully, to take any profits from QUIK and roll them into either CLSK or CPAH (or both) prior to ER, and then sell some trading shares and keep my core positions. I'm also looking to get back into SOLY and hold through the 510K filing, selling some, and holding through FDA approval.
That's the current strategy, which could change at any time of course. I'll take a look at IDXG too, and see if/how I should incorporate it into my short term strategy. So much for that, lol: finance.yahoo.com/news/soliton-files-510-k-fda-120000403.htmlSoliton Files 510(k) with FDA for RAP Device for the Reduction of Cellulite |
|
|
|
Post by magnus123 on Jul 1, 2020 13:02:30 GMT
Endra barely moved after the announcement of the 510K filing.
|
|
|
|
Post by JHam on Jul 1, 2020 14:03:03 GMT
Endra barely moved after the announcement of the 510K filing. And SOLY is only up 3%. |
|
|
|
Post by JHam on Jul 2, 2020 3:08:34 GMT
Would like to add IDXG to that list. They had no run so far, but a lot of volume and volatility in the $4 range. Great call on this one magnus! Up big AH. Some news must be about to hit tomorrow. I added a little bit to my CLSK position. I'm looking to add more, but since CPSH dumped most of its gains from the run up yesterday (25%), I am hoping to open a position there again soon as well. Q3 should be big for this company, and I'd like to accumulate a position before those numbers come out. |
|
|
|
Post by magnus123 on Jul 2, 2020 9:48:48 GMT
Would like to add IDXG to that list. They had no run so far, but a lot of volume and volatility in the $4 range. Great call on this one magnus! Up big AH. Some news must be about to hit tomorrow. I added a little bit to my CLSK position. I'm looking to add more, but since CPSH dumped most of its gains from the run up yesterday (25%), I am hoping to open a position there again soon as well. Q3 should be big for this company, and I'd like to accumulate a position before those numbers come out. Thanks! My timing was really extremely lucky. Up now 45% without news. I will look to roll some profits from IDXG to CPSH in the next days. I have now half of my position back in CLSK and look to add more today or tomorrow. |
|
|
|
Post by magnus123 on Jul 2, 2020 10:28:00 GMT
I found this company this morning: Broadwind Energy (Nasdaq: BWEN). They had already a decent rally this year, due to a strong Q1.
Quick take away from Q1:
Total revenue of $48.6 million (+17% y/y)
Total gross margin of 12.7% (+420 bps y/y)
Total net income of $1.0 million, or $0.06 per basic share
Total non-GAAP adjusted EBITDA of $3.6 million (+$1.9 million y/y)
Total orders of $33.8 million (+41% y/y)
Total backlog of $127.4 million (+57% y/y)
Total cash and availability of $19.0 million (+$11.5 million y/y)
Total debt and capital leases were $17.8 million as of March 31, 2020.
Market Cap $61.57M
It's no software play, but a strong growing and profitable company with solid cash and a low market cap despite the rally. I have yet to do more due dilligence and would appreciate to hear your opinion on this one. A nice run up into Q2 earnings could be possible.
|
|
|
|
Post by JHam on Jul 2, 2020 11:46:22 GMT
Great call on this one magnus! Up big AH. Some news must be about to hit tomorrow. I added a little bit to my CLSK position. I'm looking to add more, but since CPSH dumped most of its gains from the run up yesterday (25%), I am hoping to open a position there again soon as well. Q3 should be big for this company, and I'd like to accumulate a position before those numbers come out. Thanks! My timing was really extremely lucky. Up now 45% without news. I will look to roll some profits from IDXG to CPSH in the next days. I have now half of my position back in CLSK and look to add more today or tomorrow. You’re timing may have been a little lucky, but it took more than luck to open a position. I’m thinking today might be a slow news day since tomorrow is a market holiday. Hope I’m wrong. |
|
|
|
Post by magnus123 on Jul 2, 2020 16:34:23 GMT
Added some more QUIK shares.
|
|
|
|
Post by magnus123 on Jul 2, 2020 20:14:37 GMT
IDXG ah over $7. I have not sold yet, because i speculated a bit about a CLSK move with a 2 day pump. Maybe also a PR on monday. I will be either wrong in a gigantic way on monday, if the dump begins then, or will make a lot profit^^
|
|
|
|
Post by selluwud on Jul 2, 2020 20:27:01 GMT
IDXG ah over $7. I have not sold yet, because i speculated a bit about a CLSK move with a 2 day pump. Maybe also a PR on monday. I will be either wrong in a gigantic way on monday, if the dump begins then, or will make a lot profit^^ You sure can pick'em. Great job. |
|
|
|
Post by JHam on Jul 3, 2020 2:17:20 GMT
IDXG ah over $7. I have not sold yet, because i speculated a bit about a CLSK move with a 2 day pump. Maybe also a PR on monday. I will be either wrong in a gigantic way on monday, if the dump begins then, or will make a lot profit^^ Great job picking this one. I imagine you’ll have time to get out premarket if there is no news. |
|
|
|
Post by JHam on Jul 3, 2020 5:10:27 GMT
CPSH and CLSK won't report Q2 earnings until August, but there is a chance that they give an update before then. CLSK should have several new deals to announce this month, so I will sit tight here for now.
Next week is all about QUIK and CPAH for me.
CPAH should report earnings this next week or the week after and anxious to see if they meet or beat their updated guidance. From the update they gave back in Feb...
Fourth Quarter Ended April 30, 2020 Guidance (unaudited)
・Revenue of $3.6 million to $4.0 million, resulting in growth of 26% to 40% compared to the fourth quarter of fiscal 2019.
・Income from operations of $0.4 million to $0.8 million compared to loss from operations of $1.0 million for the fourth quarter of fiscal 2019.
Fiscal Year Ended April 30, 2020 Guidance (unaudited)
・Revenue of $11.6 million to $12.0 million, resulting in growth of 8% to 12% compared to fiscal 2019.
・Loss from operations of $0.8 million to $1.2 million compared to loss from operations of $5.2 million for fiscal 2019.
If they report $4M in revenue and $800K in income for Q4 that would be beyond spectacular. We're dealing with 89% margins here, so $12M in revenue *should* equate to around $15 pps. But remember, many stocks in this sector trade at much higher multiples. Some, like Zoom, even at 20-35x forward revenues! At a $31M market cap CPAH is not even trading at 3x trailing revenues!
What they ultimately report will probably be somewhere in between those guidance numbers, but even that would be great. Now that it is trading around $5, if these numbers hold up I would expect some deeper pockets to start buying. These next few weeks could get real interesting with this stock.
|
|
|
|
Post by JHam on Jul 3, 2020 5:23:16 GMT
I still haven't decided my long term strategy with QUIK, but if all goes as planned, I'll take some off the table after the big news hits. I am getting interested in SINT again. You can read more about them HERE. This is another low floater that ran like wild from under $1 to $2.40 (I originally bought at $.69 and sold under $1 prior to the run up). The preliminary corona data that they published was spectacular (100% response deactivating coronavirus on surfaces with their silicone nitrade technology). They will report data from further, more thorough studies soon, and I expect the data to be the same. They just closed on a $4.1M ATM at $1.72. It's now trading below that price at $1.67. It has a huge following at ST and like CLSK attracts a lot of pumpers. When it runs though, it runs. If they can verify this preliminary data in the next studies then I can't imagine it staying anywhere near the current $28M market cap. |
|
|
|
Post by JHam on Jul 3, 2020 6:41:07 GMT
I still haven't decided my long term strategy with QUIK, but if all goes as planned, I'll take some off the table after the big news hits. I am getting interested in SINT again. You can read more about them HERE. This is another low floater that ran like wild from under $1 to $2.40 (I originally bought at $.69 and sold under $1 prior to the run up). The preliminary corona data that they published was spectacular (100% response deactivating coronavirus on surfaces with their silicone nitrade technology). They will report data from further, more thorough studies soon, and I expect the data to be the same. They just closed on a $4.1M ATM at $1.72. It's now trading below that price at $1.67. It has a huge following at ST and like CLSK attracts a lot of pumpers. When it runs though, it runs. If they can verify this preliminary data in the next studies then I can't imagine it staying anywhere near the current $28M market cap. One more thing about SINT. Besides data, at any time they could announce major funding from the govt or a deal with a mask/ppe company. |
|
|
|
Post by magnus123 on Jul 3, 2020 20:49:24 GMT
I sold SINT at $0.74. it looks still cheap actually with the covid potential and high possibillity of a big pump
|
|
|
|
Post by JHam on Jul 4, 2020 3:48:41 GMT
I sold SINT at $0.74. it looks still cheap actually with the covid potential and high possibillity of a big pump Oh I didn't realize you had owned it too. They added 2,400,000 shares, so the new total is 19,378,777. Not great, however, with insider/institutional ownership calculated, the float is around 13/14M. So I'm still going to consider it a low floater. There are a lot of eyes on this stock though (31,000+ on ST), so I don't mind that it has the extra liquidity. Some misc. info about the value change after the ATM deal at the time compared to now, and the affect pf the dilution: At the time of the ATM
o/s - 16,978,679 MC - $38.7M Pricing - $2.28
Currento/s - 19,378,777 MC - $28M Pps - $1.67 A $38.7M MC today (MC at the pricing) would give a pps of $2.01 The MC at the peak of the recent run up was around $60M, or about $3.06 post dilution (it ran to $3.50 pre-market). That's about 83% higher than where we are now, and that is before the real fireworks even happen. I said all of this to make the point, that while dilution hurts, at the moment this is still a pretty good value buy. Any news from here on out should take this above $50M pretty easily, just on hype/pump alone imo. If the news is really substantive then this could really go through the roof. Here is what they said in the data release PR: "The study and testing results show promise toward developing a new category of face masks for healthcare professionals and general consumers," said Bruce Lorange, Founder, and CEO, O2TODAY. "Face masks used by healthcare workers today can capture virus particles, but the virus can remain viable in the mask, even as long 7 days after use. Inclusion of silicon nitride technology into the mask may enhance personal safety while reducing the risk of disease spread.""This antiviral discovery opens many new opportunities for SINTX. In composites, coatings, and mixtures, silicon nitride has maintained its antibacterial and osteogenic properties, even at small fractions. We believe that incorporating our material into a variety of commonly-touched surfaces will discourage viral spread, and contribute to global health by reducing the risk of disease," Dr. Bal added.finance.yahoo.com/news/sintx-technologies-announces-publication-study-192000248.htmlIf they make a deal just with mask companies, this could prove to be the biggest COVID play of them all. I think another possibility is they make a deal with the gov't to incorporate silicon nitride into ppe (personal protective equipment). If any of these things happen $5 is definitely not out of the question, and that is being pretty conservative, imo. Nothing has changed in my thesis with SINT since my initial buy. Just at the time, not knowing the future of COVID and where this was all heading (also with my job etc...) I was trying to preserve cash. I didn't want to get stuck holding onto anything. One caveat here, is that they actually did two raises recently. The first one on June 23rd at $1.50 for $5.6M. So if there is another pop, they could even do another one. They ended Q1 with $8.2M in cash, so factoring in the burn from the end of March, I'd say they probably have somewhere around $15M CoH at the moment. This doesn't concern me too much because the near term upside is good. |
|
